BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38537583)

  • 1. Exposure to per- and polyfluoroalkyl substances and high-throughput proteomics in Hispanic youth.
    Chen JC; Goodrich JA; Walker DI; Liao J; Costello E; Alderete TL; Valvi D; Hampson H; Li S; Baumert BO; Rock S; Jones DP; Eckel SP; McConnell R; Gilliland FD; Aung MT; Conti DV; Chen Z; Chatzi L
    Environ Int; 2024 Apr; 186():108601. PubMed ID: 38537583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Signatures of Youth Exposure to Mixtures of Per- and Polyfluoroalkyl Substances: A Multi-Cohort Study.
    Goodrich JA; Walker DI; He J; Lin X; Baumert BO; Hu X; Alderete TL; Chen Z; Valvi D; Fuentes ZC; Rock S; Wang H; Berhane K; Gilliland FD; Goran MI; Jones DP; Conti DV; Chatzi L
    Environ Health Perspect; 2023 Feb; 131(2):27005. PubMed ID: 36821578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of dietary intake and longitudinal measures of per- and polyfluoroalkyl substances (PFAS) in predominantly Hispanic young Adults: A multicohort study.
    Hampson HE; Costello E; Walker DI; Wang H; Baumert BO; Valvi D; Rock S; Jones DP; Goran MI; Gilliland FD; Conti DV; Alderete TL; Chen Z; Chatzi L; Goodrich JA
    Environ Int; 2024 Mar; 185():108454. PubMed ID: 38316574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with altered levels of proteins previously linked to inflammation, metabolism and cardiovascular disease.
    Dunder L; Salihovic S; Lind PM; Elmståhl S; Lind L
    Environ Int; 2023 Jul; 177():107979. PubMed ID: 37285711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlates of plasma concentrations of per- and poly-fluoroalkyl substances among reproductive-aged Black women.
    Wise LA; Wesselink AK; Schildroth S; Calafat AM; Bethea TN; Geller RJ; Coleman CM; Fruh V; Claus Henn B; Botelho JC; Harmon QE; Thirkill M; Wegienka GR; Baird DD
    Environ Res; 2022 Jan; 203():111860. PubMed ID: 34403666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
    Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
    Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotoxicity assessment of per- and polyfluoroalkyl substances mixtures in human liver cells (HepG2).
    Ojo AF; Peng C; Ng JC
    Toxicology; 2022 Dec; 482():153359. PubMed ID: 36341878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.
    Alderete TL; Jin R; Walker DI; Valvi D; Chen Z; Jones DP; Peng C; Gilliland FD; Berhane K; Conti DV; Goran MI; Chatzi L
    Environ Int; 2019 May; 126():445-453. PubMed ID: 30844580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-sectional associations between exposure to per- and polyfluoroalkyl substances and body mass index among European teenagers in the HBM4EU aligned studies.
    Schillemans T; Iszatt N; Remy S; Schoeters G; Fernández MF; D'Cruz SC; Desalegn A; Haug LS; Lignell S; Lindroos AK; Fábelová L; Murinova LP; Kosjek T; Tkalec Ž; Gabriel C; Sarigiannis D; Pedraza-Díaz S; Esteban-López M; Castaño A; Rambaud L; Riou M; Pauwels S; Vanlarebeke N; Kolossa-Gehring M; Vogel N; Uhl M; Govarts E; Åkesson A
    Environ Pollut; 2023 Jan; 316(Pt 1):120566. PubMed ID: 36334774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Perturbations Associated with an Exposure Mixture of Per- and Polyfluoroalkyl Substances in the Atlanta African American Maternal-Child Cohort.
    Liang D; Taibl KR; Dunlop AL; Barr DB; Ryan PB; Everson T; Huels A; Tan Y; Panuwet P; Kannan K; Marsit C; Jones DP; Eick SM
    Environ Sci Technol; 2023 Oct; 57(43):16206-16218. PubMed ID: 37857362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma perfluoroalkyls are associated with decreased levels of proteomic inflammatory markers in a cross-sectional study of an elderly population.
    Salihovic S; Lind L; Larsson A; Lind PM
    Environ Int; 2020 Dec; 145():106099. PubMed ID: 32916415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between per- and poly-fluoroalkyl substances and nonalcoholic fatty liver disease: A nested case-control study in northwest China.
    Wu Y; Cheng Z; Zhang W; Yin C; Sun J; Hua H; Long X; Wu X; Wang Y; Ren X; Zhang D; Bai Y; Li Y; Cheng N
    Environ Pollut; 2024 Jun; 350():123937. PubMed ID: 38631453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of per- and polyfluoroalkyl substances with maternal metabolic and inflammatory biomarkers in early-to-mid-pregnancy.
    Cinzori ME; Pacyga DC; Rosas L; Whalen J; Smith S; Park JS; Geiger SD; Gardiner JC; Braun JM; Schantz SL; Strakovsky RS
    Environ Res; 2024 Jun; 250():118434. PubMed ID: 38346483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study.
    Beglarian E; Costello E; Walker DI; Wang H; Alderete TL; Chen Z; Valvi D; Baumert BO; Rock S; Rubbo B; Aung MT; Gilliland FD; Goran MI; Jones DP; McConnell R; Eckel SP; Conti DV; Goodrich JA; Chatzi L
    Environ Res; 2024 Mar; 244():117611. PubMed ID: 38061983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with attention-deficit/hyperactivity disorder and autism spectrum disorder in children.
    Skogheim TS; Weyde KVF; Aase H; Engel SM; Surén P; Øie MG; Biele G; Reichborn-Kjennerud T; Brantsæter AL; Haug LS; Sabaredzovic A; Auyeung B; Villanger GD
    Environ Res; 2021 Nov; 202():111692. PubMed ID: 34293314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gestational and childhood exposure to per- and polyfluoroalkyl substances and cardiometabolic risk at age 12 years.
    Li N; Liu Y; Papandonatos GD; Calafat AM; Eaton CB; Kelsey KT; Cecil KM; Kalkwarf HJ; Yolton K; Lanphear BP; Chen A; Braun JM
    Environ Int; 2021 Feb; 147():106344. PubMed ID: 33418195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.
    Roth K; Yang Z; Agarwal M; Liu W; Peng Z; Long Z; Birbeck J; Westrick J; Liu W; Petriello MC
    Environ Int; 2021 Dec; 157():106843. PubMed ID: 34479135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.